Incidence of hypertension in people with HIV infection: a longitudinal observational study

Marco Gelpi1, Luanna Uchoa Karvig1, Andreas Dehlbæk Knudsen1

  • 1Viro-immunology Research Unit, Department of Infectious Diseases, University of Copenhagen, Copenhagen.

PubMed

Insights

Hypertension incidence in people with HIV (PWH) is similar to the general population. Central obesity and waist-hip ratio are key risk factors, not HIV-specific elements, emphasizing lifestyle changes for prevention.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Epidemiology

Background:

  • Cardiovascular diseases (CVD) are a major cause of death in people with HIV (PWH).
  • Hypertension is a known CVD risk factor, but its incidence and predictors in PWH are understudied.
  • Understanding hypertension development in PWH is crucial for effective CVD prevention strategies.

Purpose of the Study:

  • To investigate the incidence of hypertension in well-treated PWH.
  • To identify predictors of incident hypertension in this population.
  • To compare hypertension risk in PWH with the general population.

Main Methods:

  • A cohort of 532 PWH from the Copenhagen Comorbidity in HIV (COCOMO) study was analyzed.
  • Participants underwent baseline and 2.5-year follow-up examinations.
  • Linear and Poisson regression models were used to assess risk factors, with confounder adjustment.

Main Results:

  • The incidence of hypertension was 8.5 cases per 100 person-years of follow-up.
  • Increased waist-hip ratio (aRR 1.54) and central obesity (aRR 2.29) were significantly associated with incident hypertension.
  • No HIV-specific factors were found to be linked to the development of hypertension.

Conclusions:

  • The incidence rate of hypertension in well-treated PWH is comparable to the general population.
  • Traditional risk factors, particularly age and adipose tissue distribution, are associated with hypertension in PWH.
  • Preventative strategies should focus on lifestyle modifications and weight management rather than HIV-specific factors.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
35
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
23
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
362
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
27
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
20
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
12.0K